NICERespiratory Medicine2021Updated 2021

NICE Asthma: Diagnosis, Monitoring and Chronic Asthma Management 2021

Published by National Institute for Health and Care Excellence · 52 pages · Class I–II

RecommendedFeNO diagnostic

Step 3MART threshold

Not recommendedSABA only

Summary

Free preview

Updated NICE asthma guidance endorses FeNO testing in the diagnostic pathway and recommends MART (Maintenance and Reliever Therapy) with ICS-formoterol as preferred treatment for adults with uncontrolled asthma on low-dose ICS. Removes SABA-only prescribing from first-line.

AsthmaICSMART therapyFeNOSABAFormoterol

Key Recommendations

Evidence Grading & Drug Doses

What's New vs Previous Version

Implementation & Clinical Pearls

Full guideline access requires an account

Create a free Prognia account to read the complete guideline — including all recommendations, evidence tables, drug dosing, and clinical pearls.

Full guideline text with all recommendations

Evidence grades (Class I/II/III, Level A/B/C)

AI-generated summary and clinical pearls

Auto-logged as CPD/CME activity

Create Free Account — Instant Access Sign In

Free plan includes 10 guideline reads per day · No credit card required

Loading your page…